-transparent.png){kind=logo}
A patient with hypophosphatemic osteomalacia secondary to ingestion of large amounts of phosphate-binding antacids is presented. Vitamin D metabolites were measured during the course of his illness and recovery and demonstrated an initially elevated concentration of 1,25-dihydroxyvitamin D, an undetectable level of 24,25-dihydroxyvitamin D, and a normal level of 25-hydroxyvitamin D. These metabolites returned to normal levels when the hypophosphatemia was corrected. Bone histomorphometry showed osteomalacia with increased resorption. The possible role of altered vitamin D metabolism in the pathogenesis of this disorder is discussed.
Related Publications
J W Godsall, and
R Baron, and
K L Insogna
February 1987,
The American journal of medicine,
J W Godsall, and
R Baron, and
K L Insogna
January 1982,
Metabolic bone disease & related research,
J W Godsall, and
R Baron, and
K L Insogna
January 1986,
Advances in experimental medicine and biology,
J W Godsall, and
R Baron, and
K L Insogna
November 1992,
Fukuoka igaku zasshi = Hukuoka acta medica,
J W Godsall, and
R Baron, and
K L Insogna
June 2021,
Internal medicine (Tokyo, Japan),
J W Godsall, and
R Baron, and
K L Insogna
January 1996,
Clinical rheumatology,
J W Godsall, and
R Baron, and
K L Insogna
January 1987,
Cleveland Clinic journal of medicine,
J W Godsall, and
R Baron, and
K L Insogna
January 1952,
Tip Fakultesi mecmuasi,
J W Godsall, and
R Baron, and
K L Insogna
September 2002,
Seminars in musculoskeletal radiology,
J W Godsall, and
R Baron, and
K L Insogna
November 1991,
Gut,
